<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139602">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01972282</url>
  </required_header>
  <id_info>
    <org_study_id>90875647</org_study_id>
    <nct_id>NCT01972282</nct_id>
  </id_info>
  <brief_title>Registry on WATCHMAN Outcomes in Real-Life Utilization</brief_title>
  <acronym>EWOLUTION</acronym>
  <official_title>Registry on WATCHMAN Outcomes in Real-Life Utilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <authority>Belgium: Institutional Review Board</authority>
    <authority>Czech Republic: Ethics Committee</authority>
    <authority>France: French Data Protection Authority</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <authority>Germany: Ethics Commission</authority>
    <authority>Italy: Ethics Committee</authority>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
    <authority>Portugal: Data Protection Agency</authority>
    <authority>Portugal: Ethics Committee for Clinical Research</authority>
    <authority>Spain: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The WATCHMAN LAA Closure Technology is designed to prevent embolization of thrombi that may
      form in the LAA, thereby preventing the occurrence of ischemic stroke and systemic
      thromboembolism.  The objectives of this observational, prospective, non-randomized
      multicenter study are (1) to compile real-world clinical outcomes data for WATCHMAN LAA
      (left atrial appendage) Close Technology in patients who are implanted with the WATCHMAN
      device in a commercial clinical setting and (2) to collect real-world usage data that may be
      needed for reimbursement of WATCHMAN technology in certain countries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 1000 subjects will be enrolled in the study.  To reduce the impact of
      individual center bias, each site may include up to 45 subjects and each country may include
      a maximum of 500 patients.  Up to 70 sites (international, outside of US) will participate
      in the study.

      Primary analyses may include, but will not be limited to, the following: procedural
      complications, incidence of stroke and death.  Descriptive statistics will be used for
      baseline, procedure and follow-up data collected through the study.

      Each patient will be followed for a period of two years after enrollment according to the
      schedule and standard practice at the enrolling centers.  There will be no additional
      visits, nor procedures, for subjects who participate in the study.  Subjects are expected to
      be followed at implant, then at one post-implant visit (typically between 1-3 months of
      implant), and then annually through 2 years post implant.  An intermediate visit may be
      scheduled in a number of patients, per physician discretion.  In order to reliably capture
      patient status at study end, a follow-up window of 24 +/- 3 months will be considered
      acceptable for scheduling the last visit.

      For subjects who are not scheduled to visit the clinic for a follow-up, a subject contact
      (e.g. phone call) will ensure capture of the endpoint related information; however, it is
      recommended to perform an in-office visit for at least the first annual visit.

      Enrollment is expected to be completed in 21 months; therefore, the total study duration is
      estimated to be 48 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Procedural complications</measure>
    <time_frame>At Implant</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke</measure>
    <time_frame>2 year follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>2 year follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with non-valvular atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are eligible for a WATCHMAN device according to current international
             and local guidelines (and future revisions) and per physician discretion;

          -  Patient who are willing and capable of providing informed consent, participating in
             all testing associated with this clinical investigation at an approved clinical
             investigational center;

          -  Patients whose age is 18 years or above, or of legal age to give informed consent
             specific to state and national law.

        Exclusion Criteria:

          -  Patient who are currently enrolled in another investigational study or registry that
             would directly interfere with the current study, except when the patient is
             participating in a mandatory governmental registry, or a purely observational
             registry with no associated treatments.  Each instance should be brought to the
             attention of the sponsor to determine eligibility;

          -  Women of childbearing potential who are, or plan to become, pregnant during the time
             of the study (method of assessment upon physician's discretion);

          -  The subject is unable or not willing to complete follow-up visits and examination for
             the duration of the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Elke Sommerijns</last_name>
    <email>elke.sommerijns@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel W Hoffman</last_name>
    <phone>+1 404 702 9253</phone>
    <email>rachel.hoffman@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>OLV Ziekenhuis</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom De Potter</last_name>
    </contact>
    <investigator>
      <last_name>Tom De Potter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Homolka Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Petr Neuzil</last_name>
    </contact>
    <investigator>
      <last_name>Petr Neuzil</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Podlesi</name>
      <address>
        <city>Trinec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marian Branny</last_name>
    </contact>
    <investigator>
      <last_name>Marian Branny</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel Teiger</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel Teiger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascal Defaye</last_name>
    </contact>
    <investigator>
      <last_name>Pascal Defaye</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francois Brigadeau</last_name>
    </contact>
    <investigator>
      <last_name>Francois Brigadeau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Am Urban</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iskandar Atmowihardjo</last_name>
    </contact>
    <investigator>
      <last_name>Iskandar Atmowihardjo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite Universitatsmedizin Berlin - Campus Virchow Klinikum - Medizinische Klinik fur Kardiologie</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leif Hendrik Boldt</last_name>
    </contact>
    <investigator>
      <last_name>Leif Hendrick Boldt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum im Friedrichshain</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Kische</last_name>
    </contact>
    <investigator>
      <last_name>Stephan Kische</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Bielefeld</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carsten Israel</last_name>
    </contact>
    <investigator>
      <last_name>Carsten Israel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatklinikum Medizinische</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georg Nickenig</last_name>
    </contact>
    <investigator>
      <last_name>Georg Nickenig</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elisabeth Krankenhaus</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Schmitz</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Schmitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardio Vasculares Centrum Sankt Katharinen</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horst Sievert</last_name>
    </contact>
    <investigator>
      <last_name>Horst Sievert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardioangiologisches Centrum Bethanien</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Boris Schmidt</last_name>
    </contact>
    <investigator>
      <last_name>Boris Schmidt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Univeritatsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bathias Busch</last_name>
    </contact>
    <investigator>
      <last_name>Mathias Busch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aklepios Klinik St Georg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Bergmann</last_name>
    </contact>
    <investigator>
      <last_name>Martin Bergmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcus Sandri</last_name>
    </contact>
    <investigator>
      <last_name>Marcus Sandri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatklinikum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Norbert Klein</last_name>
    </contact>
    <investigator>
      <last_name>Norbert Klein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tommaso Gori</last_name>
    </contact>
    <investigator>
      <last_name>Tommaso Gori</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stadtisches Klinikum Neuperlach</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Harald Mudra</last_name>
    </contact>
    <investigator>
      <last_name>Harald Mudra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Bruder</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Sick</last_name>
    </contact>
    <investigator>
      <last_name>Peter Sick</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik Weissenfels</name>
      <address>
        <city>Weissenfels</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sven Mobius-Winkler</last_name>
    </contact>
    <investigator>
      <last_name>Sven Mobius-Winkler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beaumont Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Foley</last_name>
    </contact>
    <investigator>
      <last_name>David Foley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Ferrarotto Alessi</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Corrado Tamburino</last_name>
    </contact>
    <investigator>
      <last_name>Carrado Tamburino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASL TO 4 Ospedale di Cirie</name>
      <address>
        <city>Cirie</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gaetano Senatore</last_name>
    </contact>
    <investigator>
      <last_name>Gaetano Senatore</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizio Mazzone</last_name>
    </contact>
    <investigator>
      <last_name>Patrizio Mazzone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Sacro Cuore &quot;Don Calabria&quot;</name>
      <address>
        <city>Negrar</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giulio Molon</last_name>
    </contact>
    <investigator>
      <last_name>Guilio Molon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Folkeringa</last_name>
    </contact>
    <investigator>
      <last_name>Richard Folkeringa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Boersma</last_name>
    </contact>
    <investigator>
      <last_name>Lucas Boersma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Medisch Centrum Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamas Szili-Torok</last_name>
    </contact>
    <investigator>
      <last_name>Tamas Szili-Torok</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas van Mieghem</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Hospital University of Medicine</name>
      <address>
        <city>Poznan</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marek Grygier</last_name>
    </contact>
    <investigator>
      <last_name>Marek Grygier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eduardo Infante Oliveira</last_name>
    </contact>
    <investigator>
      <last_name>Eduardo Infante Oliveira</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Marta</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonio Fiarresga</last_name>
    </contact>
    <investigator>
      <last_name>Antonio Fiarresga</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Vascular Center</name>
      <address>
        <city>Krasnoyarsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexey Vladimir Protopopov</last_name>
    </contact>
    <investigator>
      <last_name>Alexey Vladimir Protopopov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>State Cardiology Research Center</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Evgeny Vladimir Merkulov</last_name>
    </contact>
    <investigator>
      <last_name>Evgeny Vladimir Merkulov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>State Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgeny Pokushalov</last_name>
    </contact>
    <investigator>
      <last_name>Evgeny Pokushalov</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yakubov Akmal</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King Fahed Medical City - Prince Salman Cardiac Center</name>
      <address>
        <city>Ryadh</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Faisal Mohammed Al Smadi Al Shrehri</last_name>
    </contact>
    <investigator>
      <last_name>Faisal Mohammed Al Smadi Al Shrehri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Cruz Gonzalez</last_name>
    </contact>
    <investigator>
      <last_name>Ignacio Cruz Gonzalez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Al Qassimi Hospital</name>
      <address>
        <city>Sharjah</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arif Al Nooryani</last_name>
    </contact>
    <investigator>
      <last_name>Arif Al Nooryani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Infirmary</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mark Turner</last_name>
    </contact>
    <investigator>
      <last_name>Mark Turner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Begley</last_name>
    </contact>
    <investigator>
      <last_name>David Begley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver Segal</last_name>
    </contact>
    <investigator>
      <last_name>Oliver Segal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brompton &amp; Harefield NHS Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Wong</last_name>
    </contact>
    <investigator>
      <last_name>Tom Wong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Crossland</last_name>
    </contact>
    <investigator>
      <last_name>David Crossland</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tim Betts</last_name>
    </contact>
    <investigator>
      <last_name>Tim Betts</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Russian Federation</country>
    <country>Saudi Arabia</country>
    <country>Spain</country>
    <country>United Arab Emirates</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>October 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Thrombus</keyword>
  <keyword>Thromboembolism</keyword>
  <keyword>Left atrial appendage</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
